The DEA (Drug Enforcement Administration) has announced that it will start allowing researchers to obtain marijuana for federally approved medical research.
The Drug Enforcement Administration (DEA) has recently increased access to research cannabis, making it easier for scientists to get their hands on the drug to study it and its effects. The DEA has been reclassifying some substances—such as cannabidiol (CBD), also known as medical marijuana—from a Schedule I to a Schedule II substance. This means that it has more medical research applications and research can go forward.
There is a lot of research that is being done on the effects of cannabis. It is still a new drug, but studies have shown that there may be medical uses for medical ailments. One of which is epilepsy. There is still more research to be done, but for now, the focus is mainly on epilepsy. Cannabis has shown to reduce seizures, and many people have become approval for medical marijuana treatments. However, many states have denied the use of medical marijuana for research. This could be changing soon as the U.S. Drug Enforcement Administration is increasing access to cannabis for medical research purposes.Cannabis should remain illegal because more research is needed. We don’t know the exact effect of legalizing cannabis because there isn’t enough research to support its therapeutic use. But the same people who spread this nonsense are standing in the way of progress. How can you say more research is needed, but then turn around and block cannabis research? That’s a great double standard! Imagine if life worked like that for everyone. Finally, after half a century, the US federal government has come of age and decided to open the doors of cannabis research to more scientists.
For decades, Mississippi was the only licensed producer of research cannabis in the United States.
American researchers who want to do research on cannabis have had only one source since 1968. That source, of course, is none other than the capital of cannabis prohibition, Mississippi. Not only are the legislators in this state corrupt, but the university cannot grow cannabis that is not even close to what is sold in legal markets. Scientists have reported receiving moldy, crusty, dusty grass for research purposes. You can literally throw a handful of seeds in your garden and produce better quality cannabis than the University of Mississippi can grow in its agriculture department.
Executive Director Rick Doblin of the Multidisciplinary Association for Psychedelic Research, or MAPS, sees the U.S. government’s decision as an important one that represents the final political hurdle for Schedule 1 drug research. The doors that are opening for new research on cannabinoids are big. In the next decade, cannabinoid therapy research in the United States could boom. As medical knowledge about cannabinoid therapy and its effects increases, it is hoped that the U.S. federal government can follow suit and amend cannabis laws accordingly.
There has always been a lack of high quality cannabis for research
Dr. Sue Sisley, president of the Scottsdale Research Institute and a leading cannabis researcher, told the media: There are thousands of different cannabis strains with unique chemical profiles and unique clinical effects, but we didn’t have access to this normal strain. The federal government’s reluctance to open the doors to cannabis research has led to its involvement in several lawsuits. The federal government has an agreement with Mississippi. Mississippi recently legalized cannabis through a voter initiative that received 74% of the vote and passed. But that didn’t last long, because the Mississippi Supreme Court decided that the people didn’t know what was good for them and destroyed the entire basis for the state’s popular initiative. Understandably, the federal government has designated Mississippi as the only state where researchers can legally access medicinal cannabis. Dr. Sue Sisley described the cannabis she received from the University of Mississippi facility as similar to green talcum powder.
This is really interesting: apparently the federal government thought it was okay for a decade to let participants with PTSD rot in pot to see if it helped. The more you learn about cannabis legalization, the more you learn that the US federal government is a bunch of crooks. Research today says the same as in 1942. The New York Academy of Medicine conducted research for the 1942 LaGuardia Committee Report on Marijuana and the 1972 Schaefer Commission. Both reports showed that the ban and the cannabis craze were based on lies and falsehoods.
The therapeutic potential of cannabis is enormous – what many growers don’t know
While the federal government continues to keep medical or even recreational cannabis away from people clinging to years of draconian prohibition, it is allowing some people to work with the DEA and FDA to study the antimicrobial properties of cannabinoid therapy to fight bacteria like MRSA. Another company that will grow cannabis for research is a research-based pharmaceutical company. It may sound scary, like we’re talking about a bunch of government agents growing weed or something, but if you look at these guys, they really seem to know what they’re doing. Let’s hope they can grow good cannabis for research purposes. I mean, at least as patients we deserve the results of research with a quality product, not something my dog would have bred.
Ashley Priest is a patient, mother, entrepreneur and activist fighting for the abolition of drug prohibition around the world, for a better future for all. Ashley is passionate about sharing knowledge about the divine plant that is cannabis. She believes that one seed can make all the difference and that together, through education, we can end the stigma that prevents cannabis from reaching its full potential worldwide.
dea federal registerdea application requirementscbd oil research,People also search for,Privacy settings,How Search works,dea federal register,dea application requirements,cbd oil research